🇺🇸 FDA
Patent

US 12378241

Pyridine derivative as FGFR and VEGFR dual inhibitors

granted A61PA61P35/00

Quick answer

US patent 12378241 (Pyridine derivative as FGFR and VEGFR dual inhibitors) held by CGeneTech (Suzhou, China) CO., Ltd. expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CGeneTech (Suzhou, China) CO., Ltd.
Grant date
Tue Aug 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P35/00